$SEEL Greetings Seels: Dexter and I have thoroughly reviewed the latest press release. I believe that each press release must be evaluated cumulatively, that is, in conjunction with all prior press releases and/or other news releases (interviews). That being said, there are some notable indications in this release in the context of other recent news. 1) there has been FDA fast track. Meaning, feedback will be faster, meetings will happen faster, testing may be completed sooner, everything will be at an accelerated rate. Factor that in. 2) Read the PR immediately prior to this one. "Upon successful completion of the Phase I studies, Seelos plans to conduct a PHASE 2 Proof of Concept (PoC) study of Acute Suicidal Ideation and Behavior (ASIB) in patients with Major Depressive Disorder (MDD)." con'd in comment
  • 5
  • 7